EGFR mutations in exon 19 deletion (19DEL) and exon 21 L858R point mutations are the two most common subtypes in NSCLC, accounting for 90% of all mutations, and referred to as sensitive mutations. Here, EGFR is linked to non-small cell lung carcinoma.